|
|
|
Your immune system only cares about the
backside of the product's bottle, do you?
|
High Dose, Highly Purified Beta Glucan
Proven Immune System
Support
|
Beta
Glucan Expand Radiation Research
WASHINGTON,
DC - November 19, 2002 - The Henry M. Jackson Foundation for the
Advancement of Military Medicine, Inc. have entered into a joint
research agreement with the Armed Forces Radiobiology Research
Institute (AFRRI) to determine the radio protective benefits of
our patented beta 1,3 glucans and to work together toward the
anticipated implementation of the research.
Radiation
exposure destroys the bone marrow and depletes the white blood
cells that defend against infection and disease. In preclinical
research, AFRRI has demonstrated that systemic yeast beta 1,3
glucans enhanced mouse resistance to sub-lethal and lethal doses
of radiation. Beta glucan stimulated bone marrow recovery of white
blood cells and increased their infection-fighting activity.
Under
the new research agreement, AFRRI will conduct a series of
studies over the next 180 days to determine the safety and
efficacy of orally administered WGP Beta Glucan to protect animals
against radiation and infectious disease. If this preclinical
research is successful, the joint team will execute a plan to
develop WGP Beta Glucan formulations that can be used in state and
federal programs designed to protect U.S. government employees,
military personnel and citizens from national disasters.
The
Henry M. Jackson Foundation for the Advancement of Military
Medicine, Inc. is a private, not-for-profit organization chartered
by Congress to support military medical research and education at
the Uniformed Services University of the Health Sciences and
throughout military medicine. Website: www.hjf.org.
The
Armed Forces Radiobiology Research Institute, Uniformed Services
University of the Health Sciences, is a triservice research
laboratory chartered in 1961 whose focus is developing potential
products in the field of radiobiology and related matters
essential to the operational and medical support of the U.S.
Department of Defense and the military services. AFRRI's mission
is to develop products that may protect military personnel against
radiation-induced immunosuppression and infectious disease.
Website:
|
